Sds22 Antibodies

Santa Cruz Biotechnology features a diverse variety of Sds22 monoclonal antibodies for advanced research in cell signaling and regulation. Sds22 monoclonal antibodies are highly effective in various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Sds22, a regulatory protein, plays a crucial role in the control of protein phosphatase 1 (PP1) activity, which is essential for numerous cellular processes, including cell division, metabolism, and signal transduction. By modulating PP1, Sds22 influences various physiological functions and is implicated in several diseases, making it a significant target for therapeutic research. Understanding the role of Sds22 in cellular mechanisms can provide insights into potential interventions for related disorders. Researchers can utilize Sds22 monoclonal antibodies to investigate specific protein interactions and cellular pathways involved in disease progression. Current studies focusing on Sds22 are uncovering new possibilities in therapeutic development and disease treatment. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cellular regulation and disease mechanisms.